{"transactions":[{"id":2044228,"issuer":{"id":8193,"kind":"organization","name":"Enveric Biosciences, Inc."},"owners":[{"id":117609,"kind":"person","name":"Kanubaddi Avani","position":1,"cik":"0001838498","reported_name":"Kanubaddi Avani","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2023-01-27T22:05:26.000Z","date":"2023-01-25","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the restricted stock units (the \"RSUs\") granted to the reporting person pursuant to the Enveric Biosciences, Inc. (the \"Company\") 2020 Long-Term Incentive Plan. For each vested restricted stock unit, the reporting person will be entitled to receive one share of common stock. The RSUs vest in four equal annual installments, with the first installment vesting upon the one year anniversary of the date of issuance."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 38,346 restricted stock units previously reported on Table II."}],"balance_after":48346,"source":{"system":"sec-edgar","filing":"0001493152-23-002800","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/890821/000149315223002800/ownership.xml","form_type":"4"}},{"id":2427127,"issuer":{"id":8193,"kind":"organization","name":"Enveric Biosciences, Inc."},"owners":[{"id":117609,"kind":"person","name":"Kanubaddi Avani","position":1,"cik":"0001838498","reported_name":"Kanubaddi Avani","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Restricted Stock Units","published_at":"2022-01-25T21:53:45.000Z","date":"2022-01-19","kind":"grant","acquired":true,"shares":1127787,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the restricted stock units (the \"RSUs\") granted to the reporting person pursuant to the Enveric Biosciences, Inc. (the \"Company\") 2020 Long-Term Incentive Plan. For each vested restricted stock unit, the reporting person will be entitled to receive one share of common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"50% of the RSUs shall vest over 4 years in equal annual installments, with the first tranche to vest on January 19, 2023. 50% of the RSUs shall vest in 3 approximately equal tranches on each of December 31, 2022, 2023 and 2024, if the Company's average VWAP (calculated as the average over the fourth calendar quarter of each of 2022, 2023 and 2024, as applicable, of the daily volume weighted average price of a share of common stock), exceeds $1.72, $1.89, $2.08, respectively."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"50% of the RSUs shall vest over 4 years in equal annual installments, with the first tranche to vest on January 19, 2023. 50% of the RSUs shall vest in 3 approximately equal tranches on each of December 31, 2022, 2023 and 2024, if the Company's average VWAP (calculated as the average over the fourth calendar quarter of each of 2022, 2023 and 2024, as applicable, of the daily volume weighted average price of a share of common stock), exceeds $1.72, $1.89, $2.08, respectively."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"50% of the RSUs shall vest over 4 years in equal annual installments, with the first tranche to vest on January 19, 2023. 50% of the RSUs shall vest in 3 approximately equal tranches on each of December 31, 2022, 2023 and 2024, if the Company's average VWAP (calculated as the average over the fourth calendar quarter of each of 2022, 2023 and 2024, as applicable, of the daily volume weighted average price of a share of common stock), exceeds $1.72, $1.89, $2.08, respectively."}],"balance_after":1127787,"derivative":{"underlying":"Common Stock","underlying_shares":1127787},"source":{"system":"sec-edgar","filing":"0001493152-22-002201","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/890821/000149315222002201/ownership.xml","form_type":"4"}},{"id":2856180,"issuer":{"id":8193,"kind":"organization","name":"Enveric Biosciences, Inc."},"owners":[{"id":117609,"kind":"person","name":"Kanubaddi Avani","position":1,"cik":"0001838498","reported_name":"Kanubaddi Avani","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2021-02-18T00:24:27.000Z","date":"2021-02-15","kind":"grant","acquired":true,"shares":789484,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents restricted stock units granted to the reporting person pursuant to the Enveric Biosciences, Inc. (the \"Company\") 2020 Long-Term Incentive Plan (the \"Plan\"). For each vested restricted stock unit, the reporting person will be entitled to receive one share of common stock upon termination of employment with or services to the Company or in connection with a change of control, as set forth in the reporting person's restricted stock unit award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third (1/3rd) of the restricted stock units vested as of December 30, 2020, and the remaining two-thirds (2/3rds) of the restricted stock units shall vest in three equal tranches, with the vesting of each tranche based on the achievement of a performance milestone established by the compensation committee of the board of directors of the Company for such tranche and as set forth in the reporting person's restricted stock unit award agreement, provided the reporting person is employed by or providing services to the Company through the applicable vesting date, and subject to certain restrictions and conditions set forth in the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"One-third (1/3rd) of the restricted stock units vested as of December 30, 2020, and the remaining two-thirds (2/3rds) of the restricted stock units shall vest in three equal tranches, with the vesting of each tranche based on the achievement of a performance milestone established by the compensation committee of the board of directors of the Company for such tranche and as set forth in the reporting person's restricted stock unit award agreement, provided the reporting person is employed by or providing services to the Company through the applicable vesting date, and subject to certain restrictions and conditions set forth in the Plan."}],"balance_after":789484,"derivative":{"underlying":"Common Stock","underlying_shares":789484},"source":{"system":"sec-edgar","filing":"0001493152-21-004172","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/890821/000149315221004172/ownership.xml","form_type":"4"}}]}